Slideshow

5 Classic Hallucinogens Studied in the Treatment of Addictions

Author(s):

Michael P. Bogenschutz, MD

This slideshow provides information about the compounds, clinically relevant attributes, approximate dose, and data under study.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
emergency
zoyas222/Adobe Stock
Fedrelina/Adobe Stock
eyetronic/Adobe Stock
Gresel/Adobe Stock
Leo/AdobeStock
Audrey Kuzmin/Adobe Stock
Orawan Pattaramonchai/Adobe Stock
Desemona72/Adobe Stock
2rogan/Adobe Stock
Related Content
GLP 1
July 7th 2025

Transformation 2.0: The GLP-1 RAs as Psychiatric Medications?

Roger S. McIntyre, MD, FRCPC
How to Talk to Teenagers About Substance Use
October 8th 2021

How to Talk to Teenagers About Substance Use

Hannah Simon, MD
Brigitte Robertson, MD
May 13th 2025

Combating Misconceptions About Alcohol Use Disorder: In Conversation With Brigitte Robertson, MD

Leah Kuntz Brigitte Robertson, MD
Lloyd Sederer, MD: A Conversation About Addiction and the Opioid Epidemic
March 19th 2021

Lloyd Sederer, MD: A Conversation About Addiction and the Opioid Epidemic

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
copilot
April 18th 2025

Copilot and Me and Addiction

Craig T. Pratt, MD, DFASAM, FAPA
female prisoner
April 7th 2025

Female Offenders: Patterns, Risk, and Assessment

Anne-Marie Hathaway, DO
© 2025 MJH Life Sciences

All rights reserved.